Charles Schwab Investment Management Inc. grew its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 18.7% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,443,713 shares of the health services provider's stock after buying an additional 384,528 shares during the period. Charles Schwab Investment Management Inc. owned 1.42% of Teladoc Health worth $22,213,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Teladoc Health by 15.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider's stock valued at $15,617,000 after buying an additional 228,004 shares during the period. Jennison Associates LLC bought a new position in shares of Teladoc Health in the 3rd quarter worth $1,544,000. Massachusetts Financial Services Co. MA boosted its position in shares of Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider's stock worth $3,397,000 after purchasing an additional 305,961 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after purchasing an additional 56,864 shares during the last quarter. Finally, Maple Rock Capital Partners Inc. bought a new position in shares of Teladoc Health in the 3rd quarter worth $11,291,000. 76.82% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Teladoc Health
In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.95% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on TDOC. The Goldman Sachs Group reduced their price target on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Oppenheimer reduced their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America raised their price target on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research report on Wednesday, February 12th. Finally, Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $11.26.
Get Our Latest Report on TDOC
Teladoc Health Stock Up 3.1 %
Shares of TDOC stock traded up $0.26 on Friday, hitting $8.43. 6,771,951 shares of the stock were exchanged, compared to its average volume of 6,038,706. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The business has a 50-day moving average of $10.42 and a 200 day moving average of $9.73. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.43.
Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Equities analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.
Teladoc Health Company Profile
(
Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
